• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Liberty Leaf Holdings Subsidiary Submits Abridgment to ACMPR Application

    Bryan Mc Govern
    Oct. 19, 2017 09:26AM PST
    Cannabis Investing News

    Liberty Leaf Holdings announced its subsidiary North Road Ventures submitted an abridgment to its Access to Cannabis for Medical Purposes Regulations application with Health Canada.

    Liberty Leaf Holdings (CSE:LIB, OTCQB:LIBFF) announced its subsidiary North Road Ventures submitted an abridgment to its Access to Cannabis for Medical Purposes Regulations (ACMPR) application with Health Canada.
    As quoted in the press release:

    With the abridgment, North Road will have a distribution model that alleviates looming supply-chain issues, for “craft” or “artisan” licensed producers. Essentially, North Road is changing its application to become distribution-focused, making the company unique in the crowded field of other cultivation based applicants.
    The abridgment includes further significant features that set North Road apart. The submission for an increase in product-vault capacity will result in a fivefold increase in products available for distribution. Also notable is the addition of cannabis oil products, expected to account for 50% or more of projected sales.

    Click here to read the full press release.

    Source: www.newswire.ca

    cannabis investingcanadaliberty leaf
    The Conversation (0)

    Go Deeper

    AI Powered
    Cannabis Investing

    Maple Leaf Prepares For Pre-License Inspection

    Cannabis Investing

    Maple Leaf Enters “Active Review” with Health Canada on its ACMPR Application

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×